Director Richelle P. Parham filed a Form 4 with the SEC on November 3, 2026, disclosing a sale of Labcorp Holdings Inc. common stock on October 30, 2026.

Key Highlights

  • Reporting person: Richelle P. Parham, listed as a Director of Labcorp Holdings Inc. (NYSE:LH)
  • Transaction: 1,078 shares of Common Stock disposed of (transaction code S) on October 30, 2026
  • Sale price: $361.22 per share
  • Remaining holdings: 2,288 shares of Common Stock held directly following the transaction
  • Filing date: November 3, 2026, signed by Kathryn W. Kyle as Attorney-in-Fact for Richelle P. Parham

Parham's October 2026 Common Stock Sale at Labcorp Holdings

According to the Form 4 filing, Richelle P. Parham, a Director of Labcorp Holdings Inc. (NYSE:LH), disposed of 1,078 shares of the company's Common Stock on October 30, 2026, at a price of $361.22 per share. The transaction is coded "S," indicating a sale. The filing was submitted on November 3, 2026, by Kathryn W. Kyle acting as Attorney-in-Fact for Parham.

Following the reported transaction, the filing discloses that Parham directly beneficially owned 2,288 shares of Labcorp Holdings Common Stock. No derivative securities transactions were reported in Table II of the filing. The form covers a single reporting person and reflects direct ownership only, with no indirect beneficial ownership reported.

The filing was made pursuant to Section 16(a) of the Securities Exchange Act of 1934, which requires officers, directors, and certain shareholders to report changes in their beneficial ownership of company securities.

What Was Disclosed

Director Richelle P. Parham disclosed a sale of 1,078 shares of Labcorp Holdings Inc. Common Stock at $361.22 per share on October 30, 2026, leaving her with a directly held position of 2,288 shares following the transaction.